色素異常症治療の世界市場レポート 2025年

色素異常症治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.3％で92億1,000万米ドルに成長します。予測期間の成長は、送達システムの強化、微生物ベースの治療、再生医療の採用、遠隔医療サービスの増加、遺伝子治療、生物製剤に起因すると考えられます。予測期間の主な動向には、皮膚の健康教育プログラム、生物学に着想を得たスキンケアソリューション、非侵襲的治療法、神経化粧品と心理皮膚科学、法的規制、安全基準などがあります。

色素異常症治療の罹患率の上昇は、今後の色素異常症治療治療市場の成長を促進すると予想されます。色素異常症治療は、遺伝、ホルモンの変化、日光への暴露、または基礎的な医学的問題を含む様々な要因によって引き起こされる、皮膚、毛髪、または目の異常または不均一な色調をもたらす状態です。これらの疾患に対する治療法には、外用薬、レーザー治療、ケミカルピーリング、マイクロダーマブレージョンなど、いくつかの方法があり、これらはすべて、アルビニズム、肝斑、白斑、色素沈着などの状態に関連する黒い斑点、斑点、不規則な皮膚の色素沈着を軽減または薄くすることを目的としています。例えば、2024年6月、米国を拠点とする政府間組織である国連は、北米と欧州では、17,000人から20,000人に1人が何らかのアルビニズムに罹患していると報告しました。しかし、サハラ以南のアフリカでは、有病率はもっと高く、タンザニアでは1,400人に1人がアルビニズムであると推定されており、ジンバブエや南部アフリカの特定の民族集団では、1,000人に1人という高い有病率も報告されています。その結果、色素異常症の有病率の増加が色素異常症治療市場の成長に拍車をかけています。

世界の可処分所得の大幅な増加は、色素異常症治療市場の拡大に大きく寄与しています。特に発展途上地域における可処分所得の増加は、化粧品や皮膚科治療に多くのリソースを割く力を個人に与えています。経済分析局が発表した2023年10月のデータでは、米国人の可処分所得が2022年第1四半期の18兆2,478億米ドルから2023年第1四半期には19兆8,802億米ドルに増加することが明らかになりました。その結果、世界の可処分所得の増加が色素異常症治療市場を牽引すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の色素異常症治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の色素異常症治療市場：成長率分析
• 世界の色素異常症治療市場の実績：規模と成長, 2019-2024
• 世界の色素異常症治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界の色素異常症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の色素異常症治療市場：治療タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 局所治療
• 皮膚剥離
• ケミカルピーリング
• レーザー治療
• 光線療法
• その他の治療の種類
• 世界の色素異常症治療市場：薬物別、実績と予測, 2019-2024, 2024-2029F, 2034F
• カルシニューリン阻害剤
• メラノサイト刺激ホルモン
• その他の薬物の種類
• 世界の色素異常症治療市場：疾病タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アルビニズム
• 白斑
• 肝斑
• 炎症後色素沈着（PIH）
• その他の疾病タイプ
• 世界の色素異常症治療市場：投与経路別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経口
• 外用
• その他の投与経路
• 世界の色素異常症治療市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 皮膚科クリニック
• 美容クリニック
• ドラッグストアと化粧品店
• eコマース
• その他の流通チャネル
• 世界の色素異常症治療市場、局所治療、治療タイプ別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチコステロイド
• レチノイド
• ハイドロキノン
• 世界の色素異常症治療市場、皮膚剥離、治療タイプ別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• マイクロダーマブレーション
• ダイヤモンドチップダーマブレーション
• クリスタルダーマブレーション
• 世界の色素異常症治療市場、ケミカルピーリング、治療タイプ別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 表面ピーリング
• ミディアムピール
• ディープピール
• 世界の色素異常症治療市場、レーザー治療のサブセグメンテーション、治療タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フラクショナルレーザー
• Qスイッチレーザー
• 強力パルス光（IPL）
• 世界の色素異常症治療市場、光線療法、治療タイプ別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• UVB光線療法
• ナローバンドUVB光線療法
• 世界の色素異常症治療市場、その他の治療タイプ、治療タイプ別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 凍結療法
• 脱色療法
• マイクロニードリング
• 多血小板血漿（PRP）療法

第7章 地域別・国別分析

• 世界の色素異常症治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の色素異常症治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 色素異常症治療市場：競合情勢
• 色素異常症治療市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
  • L'Oreal S.A. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bausch Health Companies Inc.
• Bayer AG
• Strides Pharma Science Limited
• Galderma S.A.
• Incyte Corporation
• Dr. Reddy's Laboratories Ltd.
• Laboratories Pierre Fabre
• Glenmark Pharmaceuticals Limited.
• Dermavant Sciences Inc.
• Lumenis Be Ltd.
• Accord Healthcare
• Obagi Medical Products Inc.
• Fotona d.o.o.
• Sesderma SL
• DermaMed Solutions LLC.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 色素異常症治療市場2029：新たな機会を提供する国
• 色素異常症治療市場2029：新たな機会を提供するセグメント
• 色素異常症治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pigmentation disorder treatment involves various methods and procedures aimed at addressing and managing conditions that affect the skin's pigmentation. These treatments are designed to restore or balance skin pigmentation, reduce the appearance of dark spots or patches, and improve overall skin tone and appearance.

The main types of pigmentation disorder treatments include topical treatment, dermabrasion, chemical peels, laser treatment, phototherapy, and others. Topical treatments involve the application of medications or products directly to the skin's surface to address various skin conditions, including pigmentation disorders. The treatment of pigmentation disorders utilizes various drugs such as calcineurin inhibitors, melanocyte-stimulating hormones, and others to address conditions such as albinism, vitiligo, melasma, post-inflammatory hyperpigmentation (PIH), and more. These drugs can be administered through oral, topical, and other routes and are distributed through dermatology clinics, aesthetic clinics, drugstores and cosmetic stores, e-commerce platforms, and other channels.

The pigmentation disorders treatment research report is one of a series of new reports from The Business Research Company that provides pigmentation disorders treatment market statistics, including the pigmentation disorders treatment industry's global market size, regional shares, competitors with a pigmentation disorders treatment market share, detailed pigmentation disorders treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pigmentation disorders treatment industry. This pigmentation disorders treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pigmentation disorders treatment market size has grown strongly in recent years. It will grow from $6.17 billion in 2024 to $6.69 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to topical treatment development, dermatological advancements, sunscreen and sun protection, chemical exfoliation methods, consumer awareness, and education

The pigmentation disorders treatment market size is expected to see strong growth in the next few years. It will grow to $9.21 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to enhanced delivery systems, microbiome-based therapies, regenerative medicine adoption, rise in telemedicine services, gene therapy, and biologics. Major trends in the forecast period include skin health education programs, bio-inspired skincare solutions, non-invasive treatment modalities, neurocosmetics and psychodermatology, legal regulations, and safety standards.

The rising incidence of pigmentation disorders is anticipated to drive the growth of the pigmentation disorder treatment market in the future. Pigmentation disorders are conditions that result in abnormal or uneven coloration of the skin, hair, or eyes, caused by various factors including genetics, hormonal changes, sun exposure, or underlying medical issues. Treatment options for these disorders encompass several methods, such as topical medications, laser therapy, chemical peels, and microdermabrasion, all aimed at reducing or lightening dark spots, patches, or irregular skin pigmentation associated with conditions like albinism, melasma, vitiligo, or hyperpigmentation. For instance, in June 2024, the United Nations, a US-based intergovernmental organization, reported that in North America and Europe, about 1 in every 17,000 to 20,000 individuals is affected by some form of albinism. However, the prevalence is much higher in sub-Saharan Africa, with estimates indicating that 1 in 1,400 people in Tanzania have albinism, and some populations in Zimbabwe and specific ethnic groups in Southern Africa report rates as high as 1 in 1,000. Consequently, the increasing prevalence of pigmentation disorders is fueling the growth of the pigmentation disorders treatment market.

The substantial growth of disposable incomes worldwide is a significant contributor to the expansion of the pigmentation disorder treatment market. Rising disposable incomes, particularly in developing regions, empower individuals to allocate more resources to cosmetic and dermatological treatments. Data from October 2023 published by the Bureau of Economic Analysis revealed an increase in Americans' disposable income from $18,247.8 billion in the first quarter of 2022 to $19,880.2 billion in the first quarter of 2023. Consequently, the global rise in disposable incomes is expected to drive the pigmentation disorders treatment market.

A noteworthy trend in the pigmentation disorder treatment market is the integration of technological advancements. Major companies in this market are focusing on developing innovative products utilizing advanced technologies to enhance their market position. For instance, Scientis SA introduced the Cyspera Intensive System in March 2022, a comprehensive solution leveraging dual chamber technology. This system incorporates key ingredients such as Cysteamine Isobionic-Amid Complex, AHA-Amino Acid Complex, and Isobionic-Amide Complex, effectively addressing hyperpigmentation by delivering potent antioxidant activity, balancing skin pH, and providing anti-inflammatory benefits.

Companies operating in the pigmentation disorder treatment market are also placing emphasis on the development of nutricosmetics products. The integration of nutricosmetics involves using oral supplements to improve skin health and is gaining popularity. Nutrients such as antioxidants and vitamins are promoted for their potential benefits to pigmentation and overall skin condition. For instance, in March 2023, Symrise AG launched diana food bioactives, a collection of innovative nutricosmetic ingredients designed for 'Beauty from within' products. The collection includes solutions for skin conditioning, anti-aging, skin brightening, and hair and nail care, contributing to the expanding field of cosmetic ingredients.

In February 2024, Shiseido, a Japan-based cosmetics company, acquired DDG Skincare Holdings LLC for an undisclosed sum. This strategic acquisition aligns with Shiseido's goal to enhance its portfolio with scientifically validated skincare solutions. Dr. Dennis Gross Skincare is a US-based provider of treatments for pigmentation disorders.

Major companies operating in the pigmentation disorders treatment market include AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb, L'Oreal S.A., Bausch Health Companies Inc., Bayer AG, Strides Pharma Science Limited, Galderma S.A., Incyte Corporation, Dr. Reddy's Laboratories Ltd., Laboratories Pierre Fabre, Glenmark Pharmaceuticals Limited., Dermavant Sciences Inc., Lumenis Be Ltd., Accord Healthcare, Obagi Medical Products Inc., Fotona d.o.o., Sesderma SL, DermaMed Solutions LLC., Vital Esthetique, Vivier Pharma, Arcutis Biotherapeutics, Episciences Inc., Phio Pharmaceuticals Inc., Scientis SA, Philadelphia Pharmaceutical

North America was the largest region in the pigmentation disorders treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pigmentation disorders treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pigmentation disorders treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pigmentation disorders treatment market consists of revenues earned by entities by providing pigmentation disorders treatment services such as cryotherapy, light therapy, and depigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. The pigmentation disorder treatment market also includes sales of topical creams and serums, micro needling devices, and light therapy devices that are used in pigmentation disorder treatments. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pigmentation Disorders Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pigmentation disorders treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pigmentation disorders treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pigmentation disorders treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Topical Treatment; Dermabrasion; Chemical Peels; Laser Treatment; Phototherapy; Other Treatment Types
• 2) By Drugs: Calcineurin Inhibitors; Melanocyte-Stimulating Hormone; Other Drug Types
• 3) By Type Of Disorder: Albinism; Vitiligo; Melasma; Post-Inflammatory Hyperpigmentation (PIH); Other Types Of Disorder
• 4) By Route Of Administration: Oral; Topical; Other Routes Of Administration
• 5) By Distribution Channel: Dermatology Clinics; Aesthetic Clinics; Drugstores And Cosmetic Stores; E-Commerce; Other Distribution Channels
• Subsegments:
• 1) By Topical Treatment: Corticosteroids; Retinoids; Hydroquinone
• 2) By Dermabrasion: Microdermabrasion; Diamond Tip Dermabrasion; Crystal Dermabrasion
• 3) By Chemical Peels: Superficial Peels; Medium Peels; Deep Peels
• 4) By Laser Treatment: Fractional Lasers; Q-Switched Lasers; Intense Pulsed Light (IPL)
• 5) By Phototherapy: UVB Phototherapy; Narrowband UVB Phototherapy
• 6) By Other Treatment Types: Cryotherapy; Depigmentation Therapy; Microneedling; Platelet-Rich Plasma (PRP) Therapy
• Companies Mentioned: AbbVie Inc.; Novartis AG; Sanofi S.A.; Bristol-Myers Squibb; L'Oreal S.A.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pigmentation Disorders Treatment Market Characteristics

3. Pigmentation Disorders Treatment Market Trends And Strategies

4. Pigmentation Disorders Treatment Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Pigmentation Disorders Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pigmentation Disorders Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pigmentation Disorders Treatment Market Growth Rate Analysis
• 5.4. Global Pigmentation Disorders Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pigmentation Disorders Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pigmentation Disorders Treatment Total Addressable Market (TAM)

6. Pigmentation Disorders Treatment Market Segmentation

• 6.1. Global Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Topical Treatment
• Dermabrasion
• Chemical Peels
• Laser Treatment
• Phototherapy
• Other Treatment Types
• 6.2. Global Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Calcineurin Inhibitors
• Melanocyte-Stimulating Hormone
• Other Drug Types
• 6.3. Global Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Albinism
• Vitiligo
• Melasma
• Post-Inflammatory Hyperpigmentation (PIH)
• Other Types Of Disorder
• 6.4. Global Pigmentation Disorders Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Topical
• Other Routes Of Administration
• 6.5. Global Pigmentation Disorders Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dermatology Clinics
• Aesthetic Clinics
• Drugstores And Cosmetic Stores
• E-Commerce
• Other Distribution Channels
• 6.6. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Topical Treatment, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Retinoids
• Hydroquinone
• 6.7. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Dermabrasion, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microdermabrasion
• Diamond Tip Dermabrasion
• Crystal Dermabrasion
• 6.8. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Chemical Peels, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Superficial Peels
• Medium Peels
• Deep Peels
• 6.9. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Laser Treatment, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fractional Lasers
• Q-Switched Lasers
• Intense Pulsed Light (IPL)
• 6.10. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Phototherapy, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• UVB Phototherapy
• Narrowband UVB Phototherapy
• 6.11. Global Pigmentation Disorders Treatment Market, Sub-Segmentation Of Other Treatment Types, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cryotherapy
• Depigmentation Therapy
• Microneedling
• Platelet-Rich Plasma (PRP) Therapy

7. Pigmentation Disorders Treatment Market Regional And Country Analysis

• 7.1. Global Pigmentation Disorders Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pigmentation Disorders Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pigmentation Disorders Treatment Market

• 8.1. Asia-Pacific Pigmentation Disorders Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pigmentation Disorders Treatment Market

• 9.1. China Pigmentation Disorders Treatment Market Overview
• 9.2. China Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pigmentation Disorders Treatment Market

• 10.1. India Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pigmentation Disorders Treatment Market

• 11.1. Japan Pigmentation Disorders Treatment Market Overview
• 11.2. Japan Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pigmentation Disorders Treatment Market

• 12.1. Australia Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pigmentation Disorders Treatment Market

• 13.1. Indonesia Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pigmentation Disorders Treatment Market

• 14.1. South Korea Pigmentation Disorders Treatment Market Overview
• 14.2. South Korea Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pigmentation Disorders Treatment Market

• 15.1. Western Europe Pigmentation Disorders Treatment Market Overview
• 15.2. Western Europe Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pigmentation Disorders Treatment Market

• 16.1. UK Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pigmentation Disorders Treatment Market

• 17.1. Germany Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pigmentation Disorders Treatment Market

• 18.1. France Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pigmentation Disorders Treatment Market

• 19.1. Italy Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pigmentation Disorders Treatment Market

• 20.1. Spain Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pigmentation Disorders Treatment Market

• 21.1. Eastern Europe Pigmentation Disorders Treatment Market Overview
• 21.2. Eastern Europe Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pigmentation Disorders Treatment Market

• 22.1. Russia Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pigmentation Disorders Treatment Market

• 23.1. North America Pigmentation Disorders Treatment Market Overview
• 23.2. North America Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pigmentation Disorders Treatment Market

• 24.1. USA Pigmentation Disorders Treatment Market Overview
• 24.2. USA Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pigmentation Disorders Treatment Market

• 25.1. Canada Pigmentation Disorders Treatment Market Overview
• 25.2. Canada Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pigmentation Disorders Treatment Market

• 26.1. South America Pigmentation Disorders Treatment Market Overview
• 26.2. South America Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pigmentation Disorders Treatment Market

• 27.1. Brazil Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pigmentation Disorders Treatment Market

• 28.1. Middle East Pigmentation Disorders Treatment Market Overview
• 28.2. Middle East Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pigmentation Disorders Treatment Market

• 29.1. Africa Pigmentation Disorders Treatment Market Overview
• 29.2. Africa Pigmentation Disorders Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pigmentation Disorders Treatment Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pigmentation Disorders Treatment Market, Segmentation By Type Of Disorder, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pigmentation Disorders Treatment Market Competitive Landscape And Company Profiles

• 30.1. Pigmentation Disorders Treatment Market Competitive Landscape
• 30.2. Pigmentation Disorders Treatment Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bristol-Myers Squibb Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. L'Oreal S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Pigmentation Disorders Treatment Market Other Major And Innovative Companies

• 31.1. Bausch Health Companies Inc.
• 31.2. Bayer AG
• 31.3. Strides Pharma Science Limited
• 31.4. Galderma S.A.
• 31.5. Incyte Corporation
• 31.6. Dr. Reddy's Laboratories Ltd.
• 31.7. Laboratories Pierre Fabre
• 31.8. Glenmark Pharmaceuticals Limited.
• 31.9. Dermavant Sciences Inc.
• 31.10. Lumenis Be Ltd.
• 31.11. Accord Healthcare
• 31.12. Obagi Medical Products Inc.
• 31.13. Fotona d.o.o.
• 31.14. Sesderma SL
• 31.15. DermaMed Solutions LLC.

32. Global Pigmentation Disorders Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pigmentation Disorders Treatment Market

34. Recent Developments In The Pigmentation Disorders Treatment Market

35. Pigmentation Disorders Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Pigmentation Disorders Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pigmentation Disorders Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pigmentation Disorders Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer